Q9611 (Q9611): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
19,500,000.0 Czech koruna
| |||||||||||||||
| Property / EU contribution: 19,500,000.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
780,000.0 Euro
| |||||||||||||||
| Property / EU contribution: 780,000.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 780,000.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 780,000.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
39,000,000.0 Czech koruna
| |||||||||||||||
| Property / budget: 39,000,000.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
1,560,000.0 Euro
| |||||||||||||||
| Property / budget: 1,560,000.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 1,560,000.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 1,560,000.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 16:12, 11 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
19,500,000.0 Czech koruna
0 references
39,000,000.0 Czech koruna
0 references
50 percent
0 references
4 November 2016
0 references
30 May 2018
0 references
1 June 2018
0 references
Therapharm, a.s.
0 references
50°10'4.12"N, 14°6'28.30"E
0 references
27309
0 references
Žadatel se pátým rokem zabývá průmyslovým výzkumem a vývojem v oblasti nanoterapeutik s totální biokompatibilitou. Cílem projektu je rozšířit portfolio dostupných metod a technik, tak aby bylo možné provádět většinu klíčových výzkumných aktivit interně a eliminovat tak vysoké riziko ztráty know-how. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_002/0000129
0 references